Oscar Health (OSCR): Reassessing Valuation After New Analyst Coverage and Broward Health Network Expansion

Simply Wall St.12-15

Oscar Health (OSCR) just caught fresh attention after Stephens and Co. initiated coverage, and the stock responded with a multi day climb. At the same time, a new Broward Health partnership hints at ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2591338661?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799","is_english":true,"pubTime":"2025-12-15 00:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591338661","market":"sg","top_or_hot":-1,"title":"Oscar Health (OSCR): Reassessing Valuation After New Analyst Coverage and Broward Health Network Expansion","media":"Simply Wall St.","content":"<div>\n<p>Oscar Health (OSCR) just caught fresh attention after Stephens and Co. initiated coverage, and the stock responded with a multi day climb. At the same time, a new Broward Health partnership hints at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-reassessing-valuation-after-new-analyst-co\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oscar Health (OSCR): Reassessing Valuation After New Analyst Coverage and Broward Health Network Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOscar Health (OSCR): Reassessing Valuation After New Analyst Coverage and Broward Health Network Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-15 00:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-reassessing-valuation-after-new-analyst-co><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oscar Health (OSCR) just caught fresh attention after Stephens and Co. initiated coverage, and the stock responded with a multi day climb. At the same time, a new Broward Health partnership hints at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-reassessing-valuation-after-new-analyst-co\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4162","symbol_name":"人寿与健康保险","start_time":0,"source_url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-reassessing-valuation-after-new-analyst-co","article_id":"2591338661","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-reassessing-valuation-after-new-analyst-co","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2591338661","pubTimestamp":1765729395,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Oscar Health (OSCR) just caught fresh attention after Stephens and Co. initiated coverage, and the stock responded with a multi day climb. At the same time, a new Broward Health partnership hints at real-world growth.\nSee our latest analysis for Oscar Health.\nThose catalysts are landing on top of a mixed but improving track record, with a roughly 19.8% 1 month share price return and a powerful 3 year total shareholder return of about 623%. This suggests underlying momentum is still very much...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4162":"人寿与健康保险","OSCR":"Oscar Health, Inc.","BK4551":"寇图资本持仓"},"translate_title":"Oscar Health(OSCR)：在新的分析师报道和布劳沃德健康网络扩张后重新评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1.5},"content_text":"Oscar Health (OSCR) just caught fresh attention after Stephens and Co. initiated coverage, and the stock responded with a multi day climb. At the same time, a new Broward Health partnership hints at real-world growth. See our latest analysis for Oscar Health. Those catalysts are landing on top of a mixed but improving track record, with a roughly 19.8% 1 month share price return and a powerful 3 year total shareholder return of about 623%. This suggests underlying momentum is still very much alive despite recent volatility. If Oscar’s move has you thinking more broadly about healthcare, this could be a good moment to scan other ideas using our curated healthcare stocks. But with shares now near one new target and still well below another, and with revenue growing while profits lag, is Oscar Health quietly undervalued here or is the market already baking in the next leg of growth? Most Popular Narrative: 15.7% Overvalued With Oscar Health last closing at $16.63 against a narrative fair value of $14.38, the story leans toward optimism that may already be priced in.  The analysts have a consensus price target of $11.143 for Oscar Health based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $14.0, and the most bearish reporting a price target of just $8.0.  Read the complete narrative. Want to see what kind of revenue runway, margin rebound, and future earnings multiple are needed to back this valuation story? The underlying forecasts are anything but cautious. Result: Fair Value of $14.38 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, rapid digital adoption, aggressive repricing, and Oscar’s sizable capital cushion could accelerate margin recovery and could force a rethink of today’s cautious valuation narrative. Find out about the key risks to this Oscar Health narrative. Another View: Market Multiples Point the Other Way While the narrative fair value suggests Oscar Health is 15.7% overvalued, its current price to sales ratio of 0.4 times tells a different story. That is meaningfully below both the 0.7 times peer average and a 0.6 times fair ratio that the market could move toward. In practical terms, the stock is priced as if growth will disappoint, even though earnings are forecast to improve sharply. This raises the question of whether sentiment is too cautious or whether the narrative model is simply capturing risks that multiples miss. See what the numbers say about this price — find out in our valuation breakdown. NYSE:OSCR PS Ratio as at Dec 2025 Build Your Own Oscar Health Narrative If you look at the numbers and reach a different conclusion, dig into the details and craft a personalized view in minutes with Do it your way. A great starting point for your Oscar Health research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? Do not stop at one opportunity when you can quickly scan new possibilities using targeted screeners built to uncover stocks with real potential, not just hype.  Capitalize on mispriced opportunities by using these 908 undervalued stocks based on cash flows, which highlights companies trading below what their cash flows suggest they are worth. Ride structural growth trends in technology and automation with these 26 AI penny stocks, which points you toward early leaders in intelligent software and infrastructure. Strengthen your income strategy by reviewing these 13 dividend stocks with yields > 3%, which combines attractive yields with businesses capable of sustaining their payouts.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.The New Payments ETF Is Live on NASDAQ:Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.Explore how this launch could reshape portfoliosSponsored ContentNew: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2591338661","isCrawlerRequest":true}